M. Hassani

发表

Lavendamycin antitumor agents: structure-based design, synthesis, and NAD(P)H:quinone oxidoreductase 1 (NQO1) model validation with molecular docking and biological studies.

J. Gerdes, W. Holloway, D. Holley, 2008, Journal of medicinal chemistry.

NAD(P)H:quinone oxidoreductase (NQO1)-directed lavendamycin antitumor agents: Structure-based design, molecular modeling and structure-activity studies

M. Hassani, 2007 .

Benzofuran-, benzothiophene-, indazole- and benzisoxazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1.

C. Moody, M. Hassani, H. Beall, 2013, Bioorganic & medicinal chemistry.

Indolequinone antitumour agents: correlation between quinone structure and rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase.

A. Slawin, C. Moody, M. Hassani, 2007, Organic & biomolecular chemistry.

Synthesis, metabolism and in vitro cytotoxicity studies on novel lavendamycin antitumor agents.

H. Mirzaei, R. Karki, H. Seradj, 2010, Bioorganic & medicinal chemistry.

Benzimidazole- and benzothiazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1.

C. Moody, M. Hassani, H. Beall, 2007, Organic & biomolecular chemistry.

A quantum chemical study of conformational and tautomeric preferences, intramolecular hydrogen bonding and π-electron delocalization on dinitrosomethane; in gas phase and water solution

A. Nowroozi, H. Hajiabadi, M. Hassani, 2012, Structural Chemistry.

Novel lavendamycin analogues as antitumor agents: synthesis, in vitro cytotoxicity, structure-metabolism, and computational molecular modeling studies with NAD(P)H:quinone oxidoreductase 1.

J. Gerdes, D. Holley, H. Seradj, 2005, Journal of medicinal chemistry.